FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry, in particular to crystalline dihydrate 6-(piperidin-4-yloxy)-2H-isoquinolin-1-one of formula
and a solid pharmaceutical composition thereof.
EFFECT: obtained crystalline hydrochloride dihydrate, having better stability and hygroscopicity, which is preferable in obtaining the medicinal product based on it.
16 cl, 14 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
CRYSTALLINE POLYMORPHS MONOHYDRATES OF 8-CHLORO-11-(4-METHYL-1-PIPERAZINYL)-5N-DIBENZO[B,E][1,4]DIAZEPINE (CLOZAPINE) | 2018 |
|
RU2715717C1 |
CRYSTALLINE FORMS OF [(S)-1-CARBAMOYL-2-(PHENYLPYRIMIDIN-2-YLAMINO)ETHYL]AMIDE 2-(2-METHYLAMINOPYRIMIDIN-4-YL)-1H-INDOLE-5-CARBONIC ACID | 2012 |
|
RU2631320C2 |
NEW POLYMORPHS OF CALCIUM SALT AS ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANTI-PROLIFERATING AGENTS | 2019 |
|
RU2797511C2 |
CRYSTALLINE FORMS OF FINGOLIMOD HYDROCHLORIDE | 2009 |
|
RU2549899C2 |
METHOD FOR OBTAINING PYRIMIDINE DERIVATIVES | 2011 |
|
RU2576619C2 |
SOLID FORMS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR PHARMACEUTICAL COMPOSITIONS AND USE | 2012 |
|
RU2611007C2 |
COMPOUNDS SUITABLE FOR USE AS ATR KINASE INHIBITORS | 2014 |
|
RU2687276C2 |
NEW POLYMORPH | 2011 |
|
RU2559633C2 |
4-[2-[[5-METHYL-1-(2-NAPHTHALINYL)-1H-PYRAZOL-3-YL]OXY]ETHYL]MORPHOLINE HYDROCHLORIDE POLYMORPH AND SOLVATES | 2011 |
|
RU2560150C2 |
SALTS OF EPIDERMAL GROWTH FACTOR RECEPTOR KINASE | 2013 |
|
RU2711077C2 |
Authors
Dates
2017-05-12—Published
2012-06-27—Filed